Skip to main content
. 2021 Nov 25;272(4):603–619. doi: 10.1007/s00406-021-01358-5

Fig. 3.

Fig. 3

a Treatment regimen of 94 hospitalized patients treated for a clinical diagnosis of schizophrenic disorders (ICD10 F2). As little as 9.6% of patients were treated with monotherapy, while the vast majority (62.7%) received a combination of three or more concurrent drugs. The favored treatment regimen for patients with an F2 diagnosis appears to rely on two antipsychotics plus 1 antidepressant, supplemented by medications that compensate for adverse side effects. b Treatment regimen of 226 hospitalized patients treated for a clinical diagnosis of major depressive disorders (ICD10 F3). No more than 3.5% of patients were treated with psychotherapy alone, and 15.4% with monotherapy. The vast majority (59.5%) received a combination of three or more concurrent drugs. The favored treatment regimen for patients with an F3 diagnosis appeared to rely on 2 antidepressants plus 1 antipsychotic, supplemented by medications that compensate for adverse side effects